Aiolos gene

Details Aiolos gene Aiolos gene

2005-05-10

2005-05-10

Nolan, Patrick J. (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Reexamination Certificate

active

06890534

ABSTRACT:
The invention features an Aiolos protein, and nucleic acid sequence encoding such protein. The invention also features methods of making and using an Aiolos protein, and methods of obtaining an antibody from an animal having an Aiolos deregulated cell.

REFERENCES:
patent: WO 9406814 (1994-03-01), None
patent: WO 9604372a1 (1996-02-01), None
patent: WO 9714714 (1997-04-01), None
Frosch et al. Proc. Natl. Acad Sci USA 2:1194, 1985.*
Georgopoulos et al., “Tissue-specific nuclear factors mediate expresion of the CD3-delta gene during T cell development” EMBO Journal 9:109-115 (1992).
Georgopoulos et al., “Ikaros, an early lymphoid-specific transcription factor and a putative mediator T cell commitment” SCIENCE 258:808-812 (1992).
Georgopoulos et al., Ikaros an early lymphoid restricted regulatory protein, a putative modulator for T cell specification J. Cellular Biochem. vol. Suppl. 17A:B631 (1993).
Singh et al, Molecular cloning of an enchancer binding protein: isolation by screening of an expression library with a recognition site DNA Cell 52:415-423 (1988).
van de Wetering, M. et al. “Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box”The EMBO Journal 10(1): 123-132 (1991).
von Boehmer, H. “The Developmental Biology of T Lymphocytes”Ann. Rev. Immunol.6: 309-326 (1988).
Waterman, M.L. et al. “A thymus-specific member of the HMG protein family regulates the human T cell receptor Cα enhancer”Genes&Development5: 656-669 (1991).
Weintraub, H. “The MyoD Family and Myogenesis: Redundancy, Networks, and Thresholds”Cell75: 1241-1244 (Dec. 31, 1993).
Xu, Y. et al. “LH-2: A LIM/homeodomain gene expressed in developing lymphocytes and neural cells”Proc. Natl. Acad Sci. USA90: 227-231 (1993).
Yokoyama, W.M. “Flow Cytometry Analysis Using the Becton Dickinson FACScan” inCurrent Protocols in Immunology, J.E. Coligan et al. (Eds.), Brooklyn, NY: Greene Publishing Associates, 5.4.1-5.4.14 (1992).
Zervos, A.S. et al. “Mxi1, a Protein that Specifically Interacts with Max to Bind Myc-Max Recognition Sites”Cell72: 223-232 (1993).
Oltvai, Z.N. et al. “Bcl-2 Heterodimerizes In Vivo with a Conserved Homolog, Bax, That Accelerates Programed Cell Death”Cell74: 609-619 (1993).
Oosterwegel, M. et al. “Cloning of Murine TCF-1, a T Cell-specific Transcription Factor Interacting with Functional Motifs in the CD3-ε and T Cell Receptor α Enhancers”J. Exp. Med. 173:1133-1142 (May 1991).
Oosterwegel, M. et al. “Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis”Development118: 439-448 (1993).
Philpott, K.L. et al. “Lymphoid Development in Mice Congenitally Lacking T Cell Receptor αβ-Expressing Cells”Science256: 1448-1452 (Jun. 5, 1992).
Raulet, D.H. et al. “Control of γδ T-Cell Development”Immunological Reviews120:185-204 (1991).
Read, D. and J.L. Manley “Alternatively spliced transcripts of theDrosophila tramtrackgene encode zinc finger proteins with distinct DNA binding specificities”The EMBO Journal11(3): 1035-1044 (1992).
Rodewald, H.-R. et al. “A Population of Early Fetal Thymocytes Expressing FcγRII/III Contains Precursors of T Lymphocytes and Natural Killer Cells”Cell69: 139-150 (1992).
Rolink, A. and F. Melchers “Molecular and Cellular Origins of B Lymphocyte Diversity”Cell66: 1061-1094 (1991).
Rudnicki, M.A. et al. “Inactivation of MyoD in Mice Leads to Up-Regulation of the Myogenic HLH Gene Myf-5 and Results in Apparently Normal Muscule Development”Cell71: 383-390 (1992).
Sawyers, C.L. et al. “Leukemia and the Disruption of Normal Hematopoiesis”Cell64: 337-350 (1991).
Sentman, C.L. et al. “bcl-2 Inhibits Multiple Forms of Apoptosis but Not Negative Selection in Thymocytes”Cell67:879-888 (1991).
Shinkai, Y. et al. “RAG-2 Deficient Mice Lack Mature Lymphocytes Owing to Inability to Initiate V(D)J Rearrangement”Cell68: 855-867 (1992).
Skeath, J.B. et al. “Gene regulation in two dimensions” the proneuralachaeteandscutegenes are controlled by combinations of axis-patterning genes through a common intergenic control regionGenes&Development6: 2606-2619 (1992).
Spangrude, G.J. “Enrichment of murine haemopoietic stem cells: diverging roads”Immunology Today10(10): 344-350 (1989).
Spangrude, G.J. et al. “Purification and Characterization of Mouse Hematopoeitic Stem Cells”Science241:58-62 (Jul. 1, 1988).
Spanopoulou, E. et al. “Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice”Genes&Development8: 1030-1042 (1994).
Travis, A. et al. “LEF-1, a gene encoding a lymphoid-specific with protein, an HMG domain, regulates T-cell receptor β enhancer function”Genes&Development5:880-894 (1991).
Turner, Jr., C.A. et al. “Blimp-1, a Novel Zinc Finger-Containing Protein that Can Drive the Maturation of B Lymphocytes into Immunoglobulin-Secreting Cells”Cell77: 297-306 (Apr. 22, 1994).
Hsu, T. et al. “Multiple Zinc Finger Forms Resulting from Developmentally Regulated Alternative Splicing of a Transcription Factor Gene”Science257: 1946-1950 (1992).
Ikuta, K. et al. “A Developmental Switch in Thymic Lymphocyte Maturation Potential Occurs at the Level of Hematopoietic Stem Cells”Cell62: 863-874 (1990).
Ikuta, K. et al. “Lymphocyte Development From Stem Cells”Annu. Rev. Immunol.10: 759-783 (1992).
Jiang, J. and M. Levine “Binding Affinities and Cooperative Interactions with bHLH Activators Delimit Threshold Responses to the Dorsal Gradient Morphogen”Cell72: 741-752 (1993).
Juhlin, L. and W.B. Shelley “New Staining Techniques for the Langerhans Cell”Acta Dermatovener57:289-296 (1977).
Kang, S.-M. et al. “NF-κB Subunit Regulation in Nontransformed CD4+T Lymphocytes”Science256: 1452-1456 (1992).
Karasuyama, H. et al. “The Expression of Vpre-Bλ5 Surrogate Light Chain In Early Bone Marrow Precursor B Cells of Normal and B Cell-Deficient Mutant Mice”Cell77: 133-143 (Apr. 8, 1994).
Lagasse, E. and I.L. Weissman “BCL-2 Transgene Inhibits Neutrophils Cell Death But Not Their Engulfment By Microphages”J. Biochem.0 (Suppl. 17D): 168 (Mar. 13-31, 1993).
Leiden, J.M. “Transcriptional regulation during T-cell development: The β TCR gene as a molecular model”Immunology Today13(1): 22-30 (Jan. 1992).
Lenardo, M.J. and D. Baltimore “NF-κB: A Pleiotropic Mediator of Inducible and Tissue-Specific Gene Control”Cell58: 227-229 (1989).
Li, E. et al. “Targeted Mutation of the DNA Methyltransferase Gene Results in Embryonic Lethality”Cell69: 915-926 (1992).
Li, Y.-S. et al. “The Regulated Expression of B Lineage Associated Genes during B Cell Differentiation in Bone Marrow and Fetal Liver”J. Exp. Med.178: 951-960 (1993).
Liang, P. et al. “Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization”Nucleic Acids Research21 (14): 3269-3275 (1993).
Mann, R. et al. “Construction of a Retrovirus Packaging Mutant and Its Use to Produce Helper-Free Defective Retrovirus”Cell33: 153-159 (1993).
Martin, D.I.K. et al. “Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages”Nature344: 444-447 (1990).
McDonnell, T.J. and S.J. Korsmeyer “Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)”Nature349: 254-256 (1991).
McDonnell, T.J. et al. “bcl-2-Immunoglobulin Transgenic Mice Demonstrate Extended B Cell Survival and Follicular Lymphoproliferation”Cell57: 79-88 (1989).
Metcalf, D.

Affiliated with

Also associated with

Rating

Aiolos gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aiolos gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aiolos gene will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3427317